Tuesday, June 07, 2022 12:38:36 PM
I believe that that "teaching moment" is about to begin as the preliminary results from the first 2 human studies are revielled, and the publication in a suitable medical journal of the results of the preclinical lab rat study on "healthy aging" is published!
It remains to be seen if these results will make any difference in the price of MYMD, but I do believe that the healthy aging rat study will get a blizzard of attention as the public gets a vision of a drug in pill form that will deliver a longer and healthier lifespan!
Recent MYMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 04:00:19 PM
- MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • Business Wire • 03/05/2024 02:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:13:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:27:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:57:03 PM
- MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing • Business Wire • 02/13/2024 04:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:15:12 PM
- MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis • Business Wire • 12/06/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 01:00:10 PM
- MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain • Business Wire • 10/19/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 09:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:30:23 PM
- MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 • Business Wire • 10/04/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:24:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/24/2023 09:58:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 08:21:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:30:38 PM
- FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA) • Business Wire • 08/14/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:30:47 PM
- MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results • Business Wire • 08/02/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 01:00:09 PM
- MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty • Business Wire • 07/31/2023 01:00:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM